United States COVID-19 Vaccination Preferences (CVP): 2020 Hindsight.

ABSTRACT:

Background

Shortly after the 2020 US election, initial evidence on first-generation COVID-19 vaccines showed 70-95% efficacy and minimal risks. Yet, many US adults expressed reluctance.

Aims

The aim of this study was to compare persons willing and unwilling to be vaccinated against COVID-19 and to estimate the effects of vaccination attributes on uptake: proof of vaccination, vaccination setting, effectiveness, duration of immunity, and risk of severe side effects.

Method

Between 9 and 11 November 2020, 1153 US adults completed a discrete choice experiment (DCE) on Phase 2 of the CDC Vaccination Program (August 2021). Each of its eight choice tasks had three vaccination alternatives and "no vaccination for 6 months." An opt-out inflated logit model was estimated to te

SUBMITTER: Craig BM 

PROVIDER: S-EPMC8008018 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature